Iatrogenic Disease: Clinical Trials

68 trials for Iatrogenic Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

35 completed, 14 unknown, 13 terminated, 3 not yet recruiting. 68 Phase 2, 18 Phase 3, 8 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 268Completed 35, Unknown 14, Terminated 13, Not yet recruiting 3, Withdrawn 2, Recruiting 1
Phase 318Completed 6, Unknown 6, Terminated 3, Withdrawn 2, Not yet recruiting 1
Phase 18Completed 4, Unknown 3, Not yet recruiting 1

Follow Iatrogenic Disease: new trials by email Literature Review of Iatrogenic Disease trials Research Report on Iatrogenic Disease

Trials (filtered) newest first · largest first

All 68 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Precision Modulation of Gut Microbiome Enteropathogen Colonization in Critical Illness
Synbiotic, Standard of Care (SOC) - Critical Illness
Phase 1 / Phase 2Not yet recruitingUniversity of Calgary642027-01-012026-09-10
Nebulised Colistimethate Sodium to Prevent Pediatric Ventilator-associated Pneumonia
colistimethate sodium, 0.9% Saline - Ventilator Associated Pneumonia
Phase 2 / Phase 3Not yet recruitingUniversity Hospital Fattouma Bourguiba4002027-01-012026-10-08
" Study of the Benefit of Nebulized Amikacin in the Treatment of Gram-negative Bacillus Pneumonia Acquired During Mechanical Ventilation in Patients Receiving Extracorporeal Membrane Veno-arterial Oxygenation "
Amikacin, Standard of care - Pneumonia, Bacterial, Extracorporeal Membrane Oxygenation
Phase 2RecruitingAssistance Publique - Hôpitaux de Paris262026-08-102026-08-13
Microbiome-guided Prophylaxis to Reduce Ventilator-Associated Pneumonia in Intensive Care Units: A Pilot Randomized Controlled Trial
Microbiome-guided inhaled antibiotic prophylaxis, Placebo - Critical Illness, Mechanical Ventilation
Phase 2Not yet recruitingUniversity of Calgary702026-05-012026-03-11
Phase 1/2a to Assess the Safety and Tolerability of TP-122A for the Treatment of Ventilator-Associated Pneumonia
TP-122A - Pneumonia, Ventilator-Associated
Phase 1 / Phase 2UnknownTechnophage, SA152024-09-012024-04-17
"Baricitinib for Treating Hospital-acquired Pneumonia in Critically Ill Patients With a Proinflammatory Phenotype.
Baricitinib 4 MG - Hospital-acquired Pneumonia
Phase 2 / Phase 3UnknownNantes University Hospital4502023-07-012023-06-22
Oro-nasal Decontamination to Prevent Ventilator-associated Pneumonia
Povidone-Iodine, Saline spray - Ventilator Associated Pneumonia
Phase 2 / Phase 3CompletedMenoufia University782023-06-242023-11-27
PK of BV100 in Patients VABP Suspected or Confirmed to Be Due to CRAB
BV100 plus Polymyxin B, BAT - Ventilator Associated Pneumonia
Phase 2CompletedBioVersys AG392023-04-202025-01-14
Use of Presepsin as a Marker for Immunotherapy Administration in Pneumonia
Anakinra Prefilled Syringe, Placebo - Community-acquired Pneumonia, Hospital-acquired Pneumonia
Phase 2CompletedHellenic Institute for the Study of Sepsis602023-03-062024-07-31
Red Light Photobiomodulation and Topical Disinfectants
Methylene Blue Only, Chlorhexidine Gluconate Only, Methylene Blue + Chlorhexidine Gluconate - Healthcare Associated Infection, Nosocomial Infection
Phase 1 / Phase 2CompletedOndine Biomedical Inc.282023-01-102023-04-04
Safety of Nebulized Combination Therapy BromAc® in COVID-19 Respiratory Disease
Bromelains, Acetylcysteine - COVID-19 Pneumonia, COVID-19
Phase 1 / Phase 2UnknownMucpharm Pty Ltd302022-05-012022-02-28
Intravenous Metoprolol in Septic Shock
Intravenous metoprolol tartrate, Standard Care (in control arm) - Septic Shock, Ventilator Acquired Pneumonia
Phase 2CompletedAlexandria University1002022-04-012025-01-29
Nasal Photodisinfection in All Patients Presenting for Surgery for a Wide Range of Surgical Procedures
methylene blue 0.01%/chlorhexidine gluconate 0.25% + light activation - Surgical Site Infections, Nosocomial Infection
Phase 2CompletedOndine Biomedical Inc.3222022-02-042022-08-22
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of Cefiderocol in Hospitalized Pediatric Participants
Cefiderocol, Standard of Care - Gram-negative Bacterial Infections, Bloodstream Infections (BSI)
Phase 2CompletedShionogi532020-08-212026-02-27
NO Prevention of COVID-19 for Healthcare Providers
Inhaled nitric oxide gas - Coronavirus Infections, Healthcare Associated Infection
Phase 2TerminatedMassachusetts General Hospital242020-04-072026-03-20
Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia
VC, Sterile Water for Injection - Vitamin C, Pneumonia, Viral
Phase 2TerminatedZhiYong Peng562020-02-142020-10-12
Umbilical Cord(UC)-Derived Mesenchymal Stem Cells(MSCs) Treatment for the 2019-novel Coronavirus(nCOV) Pneumonia
UC-MSCs - Pneumonia, Viral, Pneumonia, Ventilator-Associated
Phase 2UnknownZhiYong Peng162020-02-062020-07-01
Inulin for Infections in the Intensive Care Unit
Inulin Oral Suspension, Placebo Oral Suspension, Broad-spectrum antibiotics - Antibiotic Resistant Infection, Nosocomial Infection
Phase 2CompletedColumbia University942019-10-142025-06-19
Endotracheal Tubes to Prevent Ventilator-Associated Pneumonia
EVAC-PU-ETT, PVC-ETT - Ventilator-acquired Pneumonia
Phase 2CompletedYale University10742019-05-062024-09-24
Coated Devices to Decrease Infection in the Intensive Care Unit
Coated devices, Control - Critically Ill
Phase 1 / Phase 2CompletedHospital do Coracao1032019-04-062020-03-09

Showing 20 of 68. Sign in to see all of them.

Narrower conditions

Pneumonia, Ventilator-Associated (42)  ·  Cross Infection (22)  ·  Pneumonia (20)  ·  Healthcare-Associated Pneumonia (13)  ·  Critical Illness (6)  ·  Sepsis (6)  ·  Surgical Wound Infection (6)  ·  Infections (5)  ·  Pseudomonas Infections (5)  ·  Pneumonia, Bacterial (4)  ·  Bacterial Infections (3)  ·  Respiratory Tract Infections (3)  ·  Bacteremia (2)  ·  COVID-19 (2)  ·  Fever (2)

Broader conditions

Disease Attributes (68)  ·  Pathologic Processes (68)  ·  Pathological Conditions, Signs and Symptoms (68)  ·  Infections (63)  ·  Respiratory Tract Diseases (52)  ·  Lung Diseases (50)  ·  Respiratory Tract Infections (48)  ·  Cross Infection (46)  ·  Healthcare-Associated Pneumonia (35)  ·  Pneumonia (30)  ·  Bacterial Infections and Mycoses (15)  ·  Bacterial Infections (12)  ·  Inflammation (10)  ·  Systemic Inflammatory Response Syndrome (9)

Interventions

Standard of Care (4)  ·  Colistin (3)  ·  Doripenem (3)  ·  Saline Solution (3)  ·  Amikacin (2)  ·  Ascorbic Acid (2)  ·  Ceftazidime (2)  ·  Chlorhexidine (2)  ·  Cilastatin, Imipenem Drug Combination (2)  ·  Injections (2)  ·  Polymyxin B (2)  ·  Povidone-Iodine (2)  ·  Sodium Chloride (2)  ·  Toothbrushing (2)  ·  Vancomycin (2)

Sponsors

Emory University (3)  ·  Hospital Universitari Joan XXIII de Tarragona. (2)  ·  Ondine Biomedical Inc. (2)  ·  University of Calgary (2)  ·  ZhiYong Peng (2)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)  ·  Agennix (1)  ·  Aionx, Inc. (1)  ·  Alexandria University (1)  ·  Anbics Management-Services Ag (1)  ·  Angela Bianco (1)  ·  Arpida AG (1)  ·  Arsanis, Inc. (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Association Pour La Promotion A Tours De La Reanimation Medicale (1)

Countries

United States (24)  ·  France (11)  ·  Spain (7)  ·  Canada (6)  ·  China (6)  ·  Hungary (4)  ·  Russia (4)  ·  Belgium (3)  ·  Georgia (3)  ·  Greece (3)  ·  Ukraine (3)  ·  Argentina (2)  ·  Austria (2)  ·  Brazil (2)  ·  Chile (2)

Top investigators

Aaron Milstone, MD MHS (1)  ·  Alexandre Biasi, MD/PhD (1)  ·  Angela Bianco, MD (1)  ·  Antoni Torres, MD PhD (1)  ·  Avery B Nathens, MD PhD MPH (1)  ·  Christian Van Delden, MD (1)  ·  Cindy L Munro, RN,ANP,PHD (1)  ·  Cindy Munro, RN, ANP,PhD (1)  ·  Daniel E Freedberg, MD, MS (1)  ·  Daren Heyland, MD (1)  ·  David Lye, MBBS, FRACP (1)  ·  David Willms, MD (1)  ·  Deborah J Cook, MD (1)

Results publications

PMID 16980879, PMID 17076839, PMID 17119142, PMID 18461895, PMID 18991508, PMID 19482956, PMID 19765321, PMID 20463812, PMID 21287306, PMID 22488002, PMID 23357775, PMID 23363666, PMID 24981955, PMID 25050644, PMID 25317722, PMID 26472037, PMID 27080532, PMID 27234409, PMID 27260839, PMID 27419080, PMID 27480757, PMID 27965798, PMID 28159015, PMID 28186383, PMID 29041861, PMID 30526610, PMID 32335895, PMID 32526149, PMID 32580252, PMID 32595159, PMID 32641343, PMID 33570583, PMID 36289153, PMID 37068952, PMID 37947276, PMID 38676438, PMID 39230271, PMID 39806400, PMID 40237647, PMID 41319662, PMID 41552367, PMID 42047567, PMID 42497015, PMID 8888088

NIH funding

R01NR007652 (2), 2016 (1), 2019 (1), P50HL073996 (1), R01DE014685 (1), R21DK089369 (1), R33HL138650 (1), R44HD057744 (1)